The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Biomedical Research Facilities (C06 Clinical Trial Not Allowed) |
93.352 |
PAR-21-139 |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required) |
93.173 |
PAR-21-096 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-21-119 |
| BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-EY-21-001 |
| Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional) |
93.866 |
RFA-AG-21-034 |
| Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional) |
93.350 |
RFA-TR-21-008 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-21-118 |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) |
93.855 |
PAR-21-082 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
93.855 |
PAR-21-083 |
| NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed) |
93.121 |
PAR-21-108 |
| Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) |
93.350 |
RFA-TR-21-010 |
| Autism Secondary Data Analysis Research Program |
93.877 |
HRSA-21-052 |
| Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-001 |
| Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) |
93.279 |
PA-21-110 |
| Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) |
93.113, 93.855 |
RFA-AI-20-077 |
| Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed) |
93.847 |
PAR-21-062 |
| Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) |
93.113, 93.855 |
RFA-AI-20-078 |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Coordination and Dissemination Center (R24 Clinical Trial Optional) |
93.213, 93.242, 93.273, 93.279, 93.846 |
RFA-DA-21-029 |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) |
93.213, 93.242, 93.273, 93.279, 93.846 |
RFA-DA-21-030 |
| HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24) |
93.113, 93.273, 93.279, 93.286, 93.307, 93.313, 93.853 |
RFA-DA-21-023 |
| Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) |
93.213, 93.273, 93.351, 93.866 |
PAR-21-109 |
| HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) |
93.213, 93.242, 93.279 |
RFA-MH-21-145 |
| HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed) |
93.113, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.853 |
RFA-DA-21-022 |
| HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required) |
93.865 |
RFA-HD-21-031 |
| HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required) |
93.865 |
RFA-HD-21-032 |
| HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed) |
93.113, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.853 |
RFA-DA-21-020 |
| HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed) |
93.113, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.853 |
RFA-DA-21-021 |
| Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) |
93.351 |
PAR-21-089 |
| Cyber-Physical Systems |
10.310, 20.200, 47.041, 47.070, 93.286, 93.350, 93.396, 97.108 |
21-551 |
| Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) |
93.847 |
PAS-21-031 |
| Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-033 |
| Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-21-008 |
| Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-21-009 |
| Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-21-010 |
| Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed) |
93.853 |
RFA-NS-21-017 |
| Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required) |
93.847 |
RFA-DK-20-032 |
| Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed) |
93.855 |
RFA-AI-21-001 |
| Limited Competition: Revision to the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) |
93.847 |
RFA-DK-20-508 |
| Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional) |
93.837, 93.847 |
RFA-HL-21-014 |
| New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-006 |
Search Results 2361-2400 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
